Blockade of Endocannabinoid Hydrolytic Enzymes Attenuates Precipitated Opioid Withdrawal Symptoms in Mice

Δ(9)-Tetrahydrocannbinol (THC), the primary active constituent of Cannabis sativa, has long been known to reduce opioid withdrawal symptoms. Although THC produces most of its pharmacological actions through the activation of CB(1) and CB(2) cannabinoid receptors, the role these receptors play in red...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ramesh, Divya, Ross, Gracious R., Schlosburg, Joel E., Owens, Robert A., Abdullah, Rehab A., Kinsey, Steven G., Long, Jonathan Z., Nomura, Daniel K., Sim-Selley, Laura J., Cravatt, Benjamin F., Akbarali, Hamid I., Lichtman, Aron H.
Formato: Artigo
Lenguaje:Inglês
Publicado: The American Society for Pharmacology and Experimental Therapeutics 2011
Materias:
Behavioral Pharmacology
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3186294/
https://ncbi.nlm.nih.gov/pubmed/21719468
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/jpet.111.181370
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares